Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Comment by duval2002on Apr 18, 2012 9:41pm
261 Views
Post# 19810514

RE: RE: News? Couple weeks late....

RE: RE: News? Couple weeks late....
/w.sharethis.com/images/twitter_counter.png");"> /w.sharethis.com/images/facebook_counter.png");"> Technorati/w.sharethis.com/images/linkedin_counter.png");">

Traditional Chinese Medicine, known for acupuncture and herbal medicine in the USA, enters a new arena of healthy food and beverage production. Tasly Pharmaceuticals (China) and SemBioSys (Canada) have recently teamed to develop and produce healthy living products including nutritionals, beverages and foods made from the oilbodies found in plants. Together, this venture has the capability of extracting and processing the oils and proteins of plants without causing them to denature. This is accomplished with a proprietary system of extraction using a continuous cold system. The cold system creates a more valuable and higher quality state of oils and proteins than is possible using conventional heat and hexane extraction methods.

Tasly Pharmaceuticals, in a joint venture with SemBioSys Genetics Inc., has received all approvals necessary to operate a newly formed company, Tasly-SemBioSys Bio-Pharmaceutical, Technology Co., Ltd. The focus of the joint venture is to develop and produce plant based nutritional and pharmaceutical products. A heavy emphasis is on the research and development of functional foods and beverages based on oilbodies. Oilbodies are structures found in plant cells that contain lipids. Oilboides often contain essential oils, triacylglycerols, phospholipids and the protein oleosin. The following picture is a look at oilbodies in a sample of a plant:

Acupuncture  CEUs

Tasly is a leading Chinese pharmaceutical company and is China’s second largest producer of Traditional Chinese Medicine products. Tasly has a large research institute along with enormous resources in product development, planting and the manufacturing of Traditional Chinese Medicine products and pharmaceuticals. SemBioSys, based in Calgary, Alberta; brings its cold processing capabilities to the venture.

Tasly is known for its ability to produce insulin from plant based products and for producing the first FDA phase-two approved Chinese herbal medicine pill for the treatment of coronary heart disease, DanShen Dripping Pills. The dripping extract process is one of the purest and most exacting methods for isolating active ingredients from herbs thereby ensuring both quality and safety. Tasly also produces an herbal product containing Chuan Xiong, Bai Shao, Dan Gui and other herbals that is used for the treatment of headaches and cerebrovascular disease. Other Tasly products include herbal extracts, teas, cosmetics, hygiene products, medical equipment and pharmaceuticals.

<< Previous
Bullboard Posts
Next >>